PD Dr. Fabian Müller



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

A human CD22 transgenic, myc-driven lymphoma model to test effects of targeted therapies on lymphoma immune microenvironment in immunecompetent mice (2019) Wagner F, Brandl C, Petkovic S, Emmerich C, Nitschke L, Mackensen A, Müller F Conference contribution 2-Deoxyglucose induced unfolded protein response enhances efficacy of immunotoxin Moxetumomab pasudotox against lymphoma and leukemia xenografts (2019) Wagner F, Meier C, Krumbholz M, Metzler M, Mackensen A, Müller F Conference contribution Development of pseudomonas exotoxin based Duotoxins for the treatment of hematologic malignancies (2019) Ammon AM, Emmerich C, Mellenthin L, Mackensen A, Müller F Conference contribution Myc-Driven, Primary Mouse Lymphoma Expressing Human CD22 Are Highly Infiltrated By Syngeneic Immune Cells and Provide a Unique Model to Test CD22-Targeted Therapies (2018) Wagner F, Brandl C, Emmerich C, Mackensen A, Nitschke L, Müller F Conference contribution Domain II of Pseudomonas Exotoxin Is Critical for Efficacy of Bolus Doses in a Xenograft Model of Acute Lymphoblastic Leukemia (2018) Müller F, Cunningham T, Beers R, Bera TK, Wayne AS, Pastan I Journal article 5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotox (2018) Müller F, Cunningham T, Stookey S, Tai CH, Burkett S, Jailwala P, Stevenson MS, et al. Journal article Synergistic immunotoxin-paclitaxel combination against lymphoma (2017) Müller F Journal article Paclitaxel synergizes with exposure time adjusted CD22-targeting immunotoxins against B-cell malignancies (2017) Müller F, Stookey S, Cunningham T, Pastan I Journal article